Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 483 of 6351
-
New scan could spot 'Invisible' brain tumors in Cushing's patients
Diagnosis Recruiting nowThis study is designed as a single institution trial. The study utilizes safe and clinically-validated tools for preoperative workup of patients with small pituitary tumors. DDAVP stimulation and 18F-labeled fluoro-deoxyglucose (FDG) uptake for PET-imaging will be used to detect …
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Immunotherapy-Chemo cocktail aims to tame head and neck tumors
Disease control Recruiting nowThis research study is being done to assess the safety and tolerability of toripalimab in combination with cisplatin and docetaxel (PDT) induction therapy for patients with CPS-positive locally advanced head and neck squamous cell carcinoma (HNSCC).
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Hormone cycling: a new hope for advanced prostate cancer?
Disease control Recruiting nowThe objective of this study is to determine the safety and clinical effects of alternating pharmacologic (i.e. supraphysiologic) testosterone therapy with darolutamide in men with metastatic prostate cancer as first line hormonal therapy. Correlative studies will be conducted to …
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New injection could save heart muscle after attack
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, single-dose, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of SGC001 injection administered in addition to standard clinical care in Chinese patients with acu…
Phase 2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Not yet recruitingThis is a prospective, single-center, single-arm clinical study. It aims to evaluate the efficacy and safety of a new combination therapy as a first-line treatment for patients with advanced intrahepatic cholangiocarcinoma (ICC) who cannot be treated with surgery. The combined th…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug FWY003 aims to halt blinding eye disease
Disease control Recruiting nowTo characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Exercise after stroke may shield brain from dementia
Disease control Recruiting nowThe rates of cognitive decline and dementia after stroke are disproportionately high. Strategies that can protect the brain early after the stroke event could reduce the future risk of cognitive decline and dementia in these patients. Although physical exercise is usually recomme…
Sponsor: McGill University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Pedaling soon after paralysis: new trial aims to speed recovery
Disease control Recruiting nowSpinal cord injuries (SCI) are among the most catastrophic survivable events experienced by human beings. Affected individuals remain with lifelong neurological impairment involving motor, sensory, bladder and bowel functions, which in turn impacts quality of life and independenc…
Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a single pill stop lyme disease before it starts?
Prevention OngoingThis study is designed to evaluate the safety, tolerability, and pharmacokinetics of TP05 administered orally to healthy adult participants.
Phase 2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
New targeted drug hopes to shrink NRAS-Driven cancers
Disease control Recruiting nowThis is a Phase 1 first-in-human, open-label multicenter study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of RLY-8161, an NRAS-selective inhibitor, in participants with advanced NRAS-mutant melanoma a…
Phase 1 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug 608 aims to ease hidden arthritis pain
Disease control Not yet recruitingThis study will evaluate the efficacy and safety of 608 in patients with nr-axSpA.
Phase 3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
AI heart scanner could catch silent disease in thousands
Diagnosis Recruiting nowA study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New hope for young brain cancer patients: enzyme therapy targets tumors
Disease control Not yet recruitingThis is an open label, intra-patient dose escalation, to evaluate ADI-PEG 20, in combination with Temozolomide (TMZ) and radiation therapy (RT) in children, adolescents and young adult patients with newly diagnosed high grade glioma (HGG).
Phase 1/2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo aims to shrink kidney tumors before surgery
Disease control Recruiting nowThe purpose of this study is to see whether the drug casdatifan is safe and effective either by itself or in combination with the drug zimberelimab in participants with resectable clear cell renal cell carcinoma (ccRCC). The names of the study drugs involved in this study are: …
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a zapping helmet wake the unresponsive?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a new type of brain stimulation called theta-burst patterned temporal interference stimulation (tTIs) works to improve awareness in people with disorders of consciousness (DoC). The main questions it aims to answer are: 1. Does tTIs…
Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New drug aims to tame dangerous heart rhythms in genetic disorder
Disease control Recruiting nowThe goal of this clinical trial is to learn whether the study drug THRV-1268 can safely and effectively shorten the QT interval in people diagnosed with Long QT Syndrome Type 2 (LQTS 2). The study will also learn about the safety and tolerability of THRV-1268 at different doses. …
Phase 2/3 • Sponsor: Thryv Therapeutics, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New cell therapy trial targets Hard-to-Treat heart amyloidosis
Disease control Not yet recruitingRelapsed/refractory (R/R) light chain cardiac amyloidosis is associated with a poor prognosis, and cellular immunotherapy constitutes a crucial therapeutic modality for these patients. The efficacy and safety of CAR-T therapy have been reported in relevant studies; however, CAR-T…
Phase 1/2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Digital tool aims to boost emotional skills in middle schoolers
Prevention By invitation onlyEarly adolescence (ages 11-14) is a key developmental period repeatedly coupled with the onset of mental health problems. Middle schools provide a naturalistic setting in which to implement programming to prevent the development of more significant mental health problems. School-…
Sponsor: University of Oregon • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
New hope for leukemia patients: immunotherapy added to standard care
Disease control Not yet recruitingThe goal of this trial is to provide a protocol for treatment for adults with Ph-negative acute lymphoblastic leukemia (ALL) and to learn if this provides higher probability of survival than the previous one. The main question is to know if the incorporation of blinatumomab for B…
Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New shot aims to cure hepatitis b – early trial underway
Disease control Recruiting nowThis study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with Nucleos(t)ide Analogue (NAs).
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC